Previous Page  3 / 23 Next Page
Information
Show Menu
Previous Page 3 / 23 Next Page
Page Background

Page 19

Notes:

Microbiol Biotechnol Rep | Volume 1, Issue 2

November 16-17, 2017 Atlanta, Georgia, USA

Annual Congress on

Mycology and Fungal Infections

Yeast assay for amyloid aggregation in proteopathies

Zachery Deckner, Pavithra Chandramowlishwaran, Meng Sun, Denis Kiktev

and

Yury O Chernoff

Georgia Institute of Technology, USA

A

myloid proteins (including transmissible amyloids, prions) cause heritable, sporadic and infectious diseases

in humans. Formation of the amyloid fibril is postulated to occur through a two-step process. First, the

normal soluble protein is converted into small aggregates or nuclei of the prion isoform of that protein by a

process called nucleation. Second, these nuclei seed the conversion of protein molecules containing the same

or similar amino acid sequence thereby sequestering them into long fibrils. A similar molecular mechanism

is employed by yeast prions, which are not homologous to known mammalian amyloid and prion proteins

by sequence, and control heritable traits. We have developed a yeast-based assay that allows us to study the

initial nucleation mechanism of any mammalian amyloidogenic protein. Here, we show that chimeric proteins

composed of Sup35 fragments, including prion-forming domain and fused to aggregation-prone regions of

mammalian prion protein (PrP), human amyloid beta (associated with Alzheimer’s disease), human α-synuclein

(associated with Parkinson’s disease), human amylin (associated with type II diabetes), or the M-region of tumor

suppressor protein 53 (associated with many forms of cancer), nucleate new Sup35 prions even in the absence of

of the Rnq1 prion or any other pre-existing nuclei. Our data indicate that prion/amyloid properties of mammalian

amyloidogenic proteins that are detected in yeast and mammalian (or

in vitro

) systems are controlled by the same

sequence elements.

Biography

Zachery Deckner has completed his BS in Biology from GCSU and is currently a PhD student at Georgia Tech. He is working on identifying and studying new

amyloidogenic proteins implicated in various proteopathies. He has mentored undergraduuate students and wants to take up a teaching career after his graduation.

zdeckner3@gatech.edu